» Articles » PMID: 37476701

Disentangling Diagnosis and Management of Fibromyalgia

Overview
Journal J Rheum Dis
Specialty Rheumatology
Date 2023 Jul 21
PMID 37476701
Authors
Affiliations
Soon will be listed here.
Abstract

Fibromyalgia (FM) is a chronic pain condition characterized by widespread pain accompanied by symptoms such as fatigue, sleep disturbance, cognitive dysfunction, and mood disorder. The pathophysiology of FM has been unclear, leading to inconsistent diagnosis and ineffective management. Several diagnostic criteria for FM have been proposed in recent years, including the revised 2016 American College of Rheumatology (ACR) criteria, the criteria of the ACTTION-American Pain Society Pain Taxonomy (AAPT) group, and the modified 2019 Fibromyalgia Assessment Status (FAS) criteria. Despite the appearance of newer criteria for FM diagnosis, the 2016 ACR criteria demonstrate the best performance. Many randomized controlled studies and systematic reviews have shown the therapeutic efficacies of pharmacological and non-pharmacological treatments of FM. Nevertheless, further research is needed to develop better treatment options.

Citing Articles

A Comprehensive Analysis of Fibromyalgia and the Role of the Endogenous Opioid System.

Garcia-Dominguez M Biomedicines. 2025; 13(1).

PMID: 39857749 PMC: 11762748. DOI: 10.3390/biomedicines13010165.


Effectiveness of a Multicomponent Program for Fibromyalgia Patients in a Primary Care Setting (FIBROCARE Program): A Pragmatic Randomized Controlled Trial.

Caballol Angelats R, Goncalves A, Abellana R, Carrasco-Querol N, Pamies Corts A, Gonzalez Serra G J Clin Med. 2025; 14(1.

PMID: 39797245 PMC: 11721895. DOI: 10.3390/jcm14010161.


Assessment of small fiber neuropathy and distal sensory neuropathy in female patients with fibromyalgia.

Min H, Im S, Park G, Moon S Korean J Intern Med. 2024; 39(6):989-1000.

PMID: 39468927 PMC: 11569927. DOI: 10.3904/kjim.2024.038.


The problem of residual pain in the assessment of rheumatoid arthritis activity.

Motyl G, Krupka W, Maslinska M Reumatologia. 2024; 62(3):176-186.

PMID: 39055728 PMC: 11267660. DOI: 10.5114/reum/189779.


Social costs associated with fibromyalgia in Spain.

Oliva-Moreno J, Vilaplana-Prieto C Health Econ Rev. 2024; 14(1):51.

PMID: 38997577 PMC: 11245780. DOI: 10.1186/s13561-024-00527-1.


References
1.
Busch A, Barber K, Overend T, Peloso P, Schachter C . Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev. 2007; (4):CD003786. DOI: 10.1002/14651858.CD003786.pub2. View

2.
Smythe H . Unhelpful criteria sets for "diagnosis" and "assessment of severity" of fibromyalgia. J Rheumatol. 2011; 38(6):975-8. DOI: 10.3899/jrheum.110142. View

3.
Perry R, Leach V, Davies P, Penfold C, Ness A, Churchill R . An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools. Syst Rev. 2017; 6(1):97. PMC: 5433031. DOI: 10.1186/s13643-017-0487-6. View

4.
Gilron I, Chaparro L, Tu D, Holden R, Milev R, Towheed T . Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial. Pain. 2016; 157(7):1532-40. DOI: 10.1097/j.pain.0000000000000558. View

5.
Wolfe F, Clauw D, Fitzcharles M, Goldenberg D, Katz R, Mease P . The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010; 62(5):600-10. DOI: 10.1002/acr.20140. View